Nasdaq jumps 300 points as weak jobs data lowers Fed hike odds

scanx
Reviewed by
Shraddha JScanX News Team
Key Highlights
  • Nasdaq Composite gained over 300 points, closing up 1.19% at 27,190.86
  • Nonfarm payrolls rose 29,000 versus 84,000-90,000 expected; unemployment hit 4.2%
  • Odds of a Fed rate hike in October fell to 17% following the data release
  • Fear & Greed Index improved to 31 but remained in the 'Fear' zone
  • Western Digital fell sharply after Toshiba announced plans to double HDD capacity
powered bylight_fuzz_icon
52729696

*this image is generated using AI for illustrative purposes only.

The Nasdaq Composite gained more than 300 points on Friday as weaker-than-expected U.S. jobs data reduced the likelihood of a Federal Reserve rate hike. The index closed at 27,190.86, up 1.19% for the session.

Nonfarm payrolls rose by just 29,000, significantly below the expected range of 84,000-90,000. The unemployment rate ticked up to 4.2% from 4.1%. This data eased tension between a softening labor market and restrictive monetary policy, with odds of an October hike falling to 17%.

Market performance and sector trends

Despite Friday's rally, weekly performance remained mixed across major indices. The Dow Jones Industrial Average fell around 1.3% last week, while the S&P 500 slipped 0.3%. In contrast, the Nasdaq secured a weekly gain of 0.6%.

On Friday, most S&P 500 sectors closed higher. Consumer discretionary, information technology, and materials stocks recorded the biggest gains. Health care stocks bucked the trend, closing lower.

Index Friday Close Daily Change Weekly Change
Dow Jones Industrial Average 51,176.96 +250 points -1.3%
S&P 500 7,722.72 +0.73% -0.3%
Nasdaq Composite 27,190.86 +1.19% +0.6%

Corporate movers

Western Digital Corp. (NASDAQ: WDC) was the worst performer in the Russell 1000 after Toshiba announced plans to double its hard disk drive production capacity. Seagate Technology Inc. (NASDAQ: STX) also fell sharply in response to the news.

Sentiment indicators

The CNN Business Fear & Greed Index remained in the "Fear" zone with a reading of 31, improving slightly from a prior reading of 29. The index ranges from 0 (maximum fear) to 100 (maximum greed) and is calculated based on seven equal-weighted indicators.

Geopolitical tensions persisted as President Donald Trump deployed 9,000 additional troops to the Middle East and warned of possible strikes against Iran.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How might the significant miss in nonfarm payrolls influence the Federal Reserve's forward guidance and dot plot projections for the remainder of the year?

What are the potential supply chain and pricing implications for the storage industry as Toshiba moves to double its HDD production capacity?

Could the divergence between Nasdaq gains and Dow Jones losses signal a sustained rotation away from value stocks toward growth-oriented tech sectors?

like19
dislike

Nasdaq rises 0.44% on chip strength as Dow slips 1.42% for week

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Nasdaq Composite gained 0.44% for the week while Dow Jones fell 1.42%
  • RTX secured a five-year contract valued up to $24.4 billion for SM-6 interceptors
  • Integra LifeSciences lowered FY26 revenue guidance to $1.634-$1.654 billion
  • Trilogy Metals closed a $35.6 million equity investment from the Department of War
powered bylight_fuzz_icon
52577474

*this image is generated using AI for illustrative purposes only.

The Nasdaq Composite gained 0.44% for the week, closing at 27,188.02, driven by strength in semiconductor and software stocks. This contrasted sharply with the Dow Jones Industrial Average, which fell 1.42% to 51,094.96, signaling a narrow market rally as the quarter turned over.

Volatility indicators eased alongside the divergence in index performance. The CBOE Volatility Index dropped to 15.58, while the Nasdaq-100 Volatility Index closed at 21.93. In commodity markets, WTI crude oil declined 2.48% on the day to $90.57 a barrel, whereas natural gas rose 1.69% to $3.02 per MMBtu.

Corporate developments and contract wins

Several companies reported significant operational updates and financial adjustments during the period:

  • RTX (NYSE: RTX): Raytheon, an RTX business, secured a five-year contract valued up to $24.4 billion for Standard Missile-6 interceptors. The deal aims to increase availability of the multi-mission munition for the U.S. Navy.
  • Integra LifeSciences (NASDAQ: IART): The company lowered its full-year 2026 revenue outlook to $1.634 billion to $1.654 billion from $1.654 billion to $1.695 billion. Adjusted EPS guidance was cut to $2.30 to $2.40 from $2.40 to $2.50, citing impacts from a July flooding event at its Cincinnati facility.
  • Trilogy Metals (NYSE: TMQ): Reported a cash balance of $31.2 million and adjusted working capital of $30.3 million as of August 31, 2026. The company also closed a $35.6 million strategic equity investment from the Department of War.
  • Phillips Edison & Company (NASDAQ: PECO): Reaffirmed full-year 2026 earnings guidance and increased gross acquisitions guidance to $600 million to $700 million from $500 million to $600 million. Year-to-date acquisitions totaled $459.7 million.
  • Axogen (NASDAQ: AXGN): Completed the acquisition of BioCircuit Technologies. The company expects BioCircuit to contribute approximately $6 million to fourth-quarter 2026 revenue and $34 million to 2027 revenue.

Market metrics summary

Index/Asset Weekly Change Closing Level Daily Change
Nasdaq Composite +0.44% 27,188.02 +1.18%
Dow Jones Industrial Average -1.42% 51,094.96 +0.33%
S&P 500 -0.31% 7,719.34 +0.69%
Russell 2000 -0.13% 2,833.74 +0.97%
WTI Crude Oil -2.19% $90.57 -2.48%
US 10-Year Treasury Yield +8 bps 5.26% +2 bps

What the numbers show

A divergence is evident between large-cap technology performance and broader market breadth. While the Nasdaq posted a weekly gain of 0.44%, the Russell 2000 slipped 0.13% and the Dow fell 1.42%. This indicates that the weekly equity gain was concentrated in specific sectors rather than driven by broad-based participation. Additionally, Integra LifeSciences' guidance reduction highlights how operational disruptions can directly impact revenue forecasts, with the full-year range narrowing by approximately $20 million at the midpoint.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How might the widening divergence between the Nasdaq and the Dow Jones influence institutional asset allocation strategies in the upcoming quarter?

Will the $24.4 billion RTX contract trigger a broader revaluation of defense sector valuations amid ongoing geopolitical tensions?

What are the potential ripple effects of Integra LifeSciences' guidance cut on supply chain reliability perceptions within the medical device sector?

like18
dislike